Your browser doesn't support javascript.
loading
Menstrual and reproductive factors, and hormonal contraception use: associations with non-Hodgkin lymphoma in a pooled analysis of InterLymph case-control studies.
Kane, E V; Roman, E; Becker, N; Bernstein, L; Boffetta, P; Bracci, P M; Cerhan, J R; Chiu, B C-H; Cocco, P; Costas, L; Foretova, L; Holly, E A; La Vecchia, C; Matsuo, K; Maynadie, M; Sanjose, S; Spinelli, J J; Staines, A; Talamini, R; Wang, S S; Zhang, Y; Zheng, T; Kricker, A.
Afiliación
  • Kane EV; Epidemiology and Genetics Unit, Department of Health Sciences, University of York, York, UK. Electronic address: eleanor.kane@egu.york.ac.uk.
  • Roman E; Epidemiology and Genetics Unit, Department of Health Sciences, University of York, York, UK.
  • Becker N; Division of Cancer Epidemiology German Cancer Research Centre, Heidelberg, Germany.
  • Bernstein L; Division of Cancer Etiology, Department of Population Sciences, Beckham Research Institute of the City of Hope Duarte, USA.
  • Boffetta P; Institute for Translational Epidemiology, The Tisch Cancer Institute, Mount Sinai School of Medicine, New York, USA; International Prevention Research Institute, Lyon, France.
  • Bracci PM; Department of Epidemiology and Biostatistics, University of California at San Francisco, San Francisco.
  • Cerhan JR; Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester.
  • Chiu BC; Division of Biological Sciences, Department of Health Studies, University of Chicago, Chicago, USA.
  • Cocco P; Occupational Health Section, Department of Public Health, University of Cagliari, Italy.
  • Costas L; Unit of Infections and Cancer (UNIC), Cancer Epidemiology Research Programme, IDIBELL, Catalan Institute of Oncology, Barcelona, Spain.
  • Foretova L; Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
  • Holly EA; Department of Epidemiology and Biostatistics, University of California at San Francisco, San Francisco.
  • La Vecchia C; Istituto di Ricerche Farmacologiche 'Mario Negri' and Department of Occupational Medicine, Universitá degli Studi di Milano, Milan, Italy.
  • Matsuo K; Aichi Cancer Center, Division of Epidemiology and Prevention, Nagoya, Japan.
  • Maynadie M; Registre des Hemopathies Malignes de Cote d'Or, EA 4184, Faculte de Medecine de Dijon, Dijon, France.
  • Sanjose S; Unit of Infections and Cancer (UNIC), Cancer Epidemiology Research Programme, IDIBELL, CIBERESP, Catalan Institute of Oncology, Barcelona, Spain.
  • Spinelli JJ; Cancer Control Research Program, BC Cancer Agency, Vancouver, British Columbia, Canada.
  • Staines A; School of Public Health, Public Health University College, Dublin, Ireland.
  • Talamini R; Centro di Riferimento Oncologico, Aviano, Italy.
  • Wang SS; Division of Cancer Etiology, Department of Population Sciences, Beckham Research Institute of the City of Hope Duarte, USA.
  • Zhang Y; Yale University School of Public Health, New Haven, USA.
  • Zheng T; Yale University School of Public Health, New Haven, USA.
  • Kricker A; Sydney School of Public Health, The University of Sydney, Sydney, Australia.
Ann Oncol ; 23(9): 2362-2374, 2012 Sep.
Article en En | MEDLINE | ID: mdl-22786757
BACKGROUND: The two most common forms of non-Hodgkin lymphoma (NHL) exhibit different sex ratios: diffuse large B-cell lymphoma (DLBCL) occurs more frequently in men and follicular lymphoma (FL) more frequently in women. Looking among women alone, this pooled analysis explores the relationship between reproductive histories and these cancers. MATERIALS AND METHODS: Self-reported reproductive histories from 4263 women with NHL and 5971 women without NHL were pooled across 18 case-control studies (1983-2005) from North America, Europe and Japan. Study-specific odd ratios (ORs) and confidence intervals (CIs) were estimated using logistic regression and pooled using random-effects meta-analyses. RESULTS: Associations with reproductive factors were found for FL rather than NHL overall and DLBCL. In particular, the risk of FL decreased with increasing number of pregnancies (pooled OR(trend) = 0.88, 95% CI 0.81-0.96). FL was associated with hormonal contraception (pooled OR = 1.30, 95% CI 1.04-1.63), and risks were increased when use started after the age of 21, was used for <5 years or stopped for >20 years before diagnosis. DLBCL, on the other hand, was not associated with hormonal contraception (pooled OR = 0.87, 95% CI 0.65-1.16). CONCLUSIONS: Hormonal contraception is associated with an increased risk of FL but not of DLBCL or NHL overall.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfoma no Hodgkin / Historia Reproductiva / Anticonceptivos Hormonales Orales / Inhibición de la Ovulación Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Female / Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2012 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfoma no Hodgkin / Historia Reproductiva / Anticonceptivos Hormonales Orales / Inhibición de la Ovulación Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Female / Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2012 Tipo del documento: Article